ROIV

Roivant Sciences Ltd. Common Shares

39.77

USD

-0.21

-0.53%

Sep 18, 15:59 UTC -4

Closed

After-Market

40.33

+0.55

+1.40%

Roivant Sciences Ltd. Common Shares Profile

About

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

Matthew Gline

Headquarters

7th Floor 50 Broadway
LONDON, X0 SW1H 0DB, UNITED KINGDOM

Auditor

Ernst & Young LLP

Share holders

Employees

721

Roivant Sciences Ltd. Common Shares Statistics

Valuation Measures

Market Capitalization²

29.13B

Enterprise Value

27.88B

Enterprise Value/EBITDA(ttm)

-46.99

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.79K

Price to Book(mrq)

5.81

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

81.38%

Operating Margin(ttm)

-15224.35%

Profit Margin(ttm)

-5417.09%

Return on Equity(ttm)

-22.94%

Return on Invested Capital(ttm)

-8.94%

Return on Assets(ttm)

-21.53%

Income Statement

Revenue(ttm)

7.53M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

6.12M

EBITDA(ttm)³

-593.29M

Net Income Available to Common(ttm)

-266.25M

Diluted EPS(ttm)

-0.53

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

160.27%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

722.32M

Dividend Yield

0.00%

Float⁴

658.76M

% Held by Insiders

8.80%

% Held by Institutions

64.76%

Balance Sheet

Total Cash(mrq)

3.84B

Total Cash Per Share(mrq)

5.32

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.72%

Quick Ratio(mrq)

16.72%

Book Value Per Share(mrq)

6.81

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-270.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.